Pentixapharm

is devoted to improving the life of patients with malignant diseases through targeted molecular diagnostic and therapy based on innovative nuclear medicine.

 

OFFICE
Pentixapharm AG

Headquarter
Bismarckstraße 13
97080 Würzburg
Germany

Robert-Rössle-Str. 10
13125 Berlin
Germany

Mail: info@pentixapharm.com